Navigation path

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
Human resources & mobility
Industrial research
Information society
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
SMEs
Social sciences and humanities
Space
Special Collections
Transport

Countries
Countries
  Argentina
  Australia
  Austria
  Belarus
  Belgium
  Benin
  Brazil
  Bulgaria
  Cameroon
  Canada
  Chile
  China
  Colombia
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Finland
  France
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Ireland
  Israel
  Italy
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lithuania
  Luxembourg
  Malta
  Mexico
  Montenegro
  Morocco
  Namibia
  Netherlands
  Nigeria
  Norway
  Peru
  Poland
  Portugal
  Romania
  Russia
  Senegal
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Swaziland
  Sweden
  Switzerland
  Taiwan
  Tunisia
  Turkey
  Ukraine
  United Kingdom
  United States


   Infocentre

Last Update: 03-06-2014  
Related category(ies):
Health & life sciences

 

Countries involved in the project described in the article:
Spain
Add to PDF "basket"

Keeping sight when the eyes age

Fading eyesight is a natural consequence of ageing. Presbyopia is a particular ocular condition that can affect everyone after the age of 45, hampering the ability to focus and leading to cataracts (the clouding of the eye lens) later in life.

Photo of an eye

© nastia1983 fotolia

Optical aids to perform visual tasks exist, but they are far away from the ideal treatment which should rely on the restoration of the dynamic and continuous focusing ability of the eye. However, new innovative solutions to cure presbyopia are now emerging thanks to an EU-funded research project that is developing multifocal corrections and accommodating lenses.

The project, called PRESBYOPIA, is researching non-invasive techniques to study the eye’s structural properties and better understand the visual mechanics of its crystalline lens. The goal is to cure the condition by developing bio-inspired intraocular lenses that can mimic the dynamic and continuous focusing ability of the eye. These replacement lenses would thus have to be flexible and sophisticated enough to mimic the structure of the crystalline lens of a young eye.

The project team includes physicists, visual scientists, material and biomechanical engineers, examining the eye’s ability to change its shape to focus on near and distant objects and elucidating the mechanisms driving presbyopia, including the loss of elasticity of the crystalline lens.

“Novel high resolution and high speed 3D imaging technologies are allowing us to investigate the physical properties of the crystalline lens and to understand how they change with aging,” says PRESBYOPIA’s Principal Investigator, ERC Advanced Grantee, Prof. Susana Marcos, director at the Spanish National Research Council’s Institute of Optics in Madrid (Consejo Superior de Investigaciones Científicas, Instituto de Óptica).

The crystalline lens is about 4mm thick and 10mm in diameter, and extremely complex, able to increase its optical power and reduce light losses caused by reflection from its surface. The only current treatment available for cataracts is to surgically remove the lens and replace it with an intraocular lens implant.

The PRESBYOPIA project has designed and developed new multifocal and accommodative intraocular lenses, currently being tested using experimental simulations that provide the patient with a multifocal vision experience. These experiments are allowing the researchers to look for the optimal optical lens designs, and to understand the role of ocular optics and neural adaptation on visual perception with these lenses.

“We have also developed an innovative accommodative lens concept, which we have just recently sent to the Munich-based European Patent Office. We now face the challenge of testing this lens,” explains Marcos.

The project has already licensed the patent for one of the multifocal lens designs to a European company, and filed two other patents on accommodative lens design and instrumentation for screening candidates for multifocal intraocular lenses. With estimated revenues for the intraocular lens market of $3.1 billion worldwide, the PRESBYOPIA project fills a clear niche in this fast-growing market.

 

Project details

  • Project acronym: PRESBYOPIA
  • Participants:Spain (Coordinator)
  • Project FP7 294099
  • Total costs: € 2 399 548
  • EU contribution: € 2 399 548
  • Duration: May 2012 - April 2017

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also
Project web site
Project information on CORDIS






  Top   Research Information Center